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Inhibitory neurotransmission in amygdala is impor-
tant for fear learning and memory. However, mecha-
nisms that control the inhibitory activity in amygdala
are not well understood. We provide evidence that
neuregulin 1 (NRG1) and its receptor ErbB4 tyrosine
kinase are critical for maintaining GABAergic activity
in amygdala. Neutralizing endogenous NRG1, inhi-
bition, or genetic ablation of ErbB4, which was ex-
pressed in a majority of palvalbumin (PV)+ neurons
in amygdala, reduced GABAergic transmission and
inhibited tone-cued fear conditioning. Specific abla-
tion of ErbB4 in PV+ neurons reduced eIPSC/eEPSC
ratios and impaired fear conditioning. Notably,
expression of ErbB4 in amygdala was sufficient to
diminish synaptic dysfunction and fear conditioning
deficits in PV-ErbB4/ mice. These observations
indicated that NRG1 signaling maintains high
GABAergic activity in amygdala and, thus, regulates
fear memory. Considering that both NRG1 and
ErbB4 are susceptibility genes of schizophrenia,
our study sheds light on potential pathophysiological
mechanisms of this disorder.
INTRODUCTION
The ability to learn, remember, and recall is critical for human
beings to think, predict the future, and alter behavior accord-
ingly. Emotionally arousing experiences, both unpleasant and
pleasant, are better remembered. Compelling evidence indi-
cates a critical role of the amygdala in acquiring and storing last-
ing emotional memories, memory consolidation, andmodulating
emotionally related memory in other brain areas (Davis andWhalen, 2001; LeDoux, 2000; McGaugh, 2004; Sah et al.,
2003). The amygdala is a group of nuclei in the medial temporal
lobes of the brain. Its basolateral nuclei (i.e., basolateral amyg-
dala; BLA) integrate sensory inputs from the thalamus and cortex
and send projections to the central nuclei and, eventually, the
brainstem and hypothalamus (LeDoux et al., 1988; McDonald,
1998; Petrovich and Swanson, 1997; Turner and Herkenham,
1991; Veening et al., 1984). A lesion of nuclei in amygdala impairs
emotion- or fear-associated memories (King, 1958). Fear condi-
tioning induces long-term potentiation (LTP) of synaptic currents
in the amygdala (McKernan and Shinnick-Gallagher, 1997;
Rogan et al., 1997).
Amygdala pyramidal neurons are regulated by local
GABAergic interneurons, which account for 10%–15% of the
neuronal population in amygdala (Lang and Pare´, 1998; Li
et al., 1996; Mahanty and Sah, 1998; Sah et al., 2003; Sugita
et al., 1993; Szinyei et al., 2000; Woodruff and Sah, 2007). The
GABAergic activity of amygdala has been implicated in con-
trolling the acquisition and expression of different measures of
conditioned and unconditioned fear (Ehrlich et al., 2009; Johan-
sen et al., 2011). For example, amygdala projection neurons
are heavily innervated by GABAergic interneurons that control
their activity (Li et al., 1996; Szinyei et al., 2000). Alteration of
GABAergic transmission in amygdala interferes with the acquisi-
tion and retrieval of conditioned fear memories (Guarraci et al.,
1999; Sanger and Joly, 1985). Enhancing and reducing efficacy
of GABAergic transmission interferes with the acquisition of
extinction and impairs extinction memory retrieval, respectively
(Harris and Westbrook, 1998; Hart et al., 2009). However, in
contrast to cortex and hippocampus, regulatory mechanisms
of GABAergic activity in the amygdala have not been studied
as extensively.
Neuregulin 1 (NRG1) is a family of growth factors that contains
the epidermal growth factor (EGF)-like domain (Buonanno, 2010;
Falls, 2003; Liu et al., 2011; Mei and Nave, 2014; Mei and Xiong,
2008). NRG1 acts by stimulating ErbB tyrosine kinases. ErbB4 is
the only autonomous ErbB kinase that can both bind NRG1 andNeuron 84, 835–846, November 19, 2014 ª2014 Elsevier Inc. 835
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Xiong, 2008; Sweeney et al., 2000; Yin et al., 2013a). It is inter-
esting that ErbB4 is expressed specifically in interneurons (Abe
et al., 2011; Fazzari et al., 2010; Huang et al., 2000; Lai and
Lemke, 1991; Neddens and Buonanno, 2011; Ting et al., 2011;
Vullhorst et al., 2009; Woo et al., 2007; Yau et al., 2003; Yin
et al., 2013b); NRG1, via stimulating ErbB4, promotes GABA
release and regulates the activity of pyramidal neurons in the hip-
pocampus and cortex (Chen et al., 2010a; Woo et al., 2007).
NRG1 mutation during development impairs LTP at cortical-
amygdala synapses and multiple forms of glutamatergic synap-
tic plasticity in the amygdala (Jiang et al., 2013). Moreover,
ErbB4 null mutant mice exhibit deficits in tone-cued fear condi-
tioning, a behavioral paradigm largely dependent on the amyg-
dala (Shamir et al., 2012). These observations suggest a role of
NRG1-ErbB4 signaling in regulating the function of amygdala.
However, little is known about underlying mechanisms. It was
reported that ErbB4+ and PV+ cells were rare in amygdala
BLA. By using a white-noise-cued paradigm, ErbB4 in PV+ inter-
neurons was shown to be dispensable for fear conditioning (Sha-
mir et al., 2012).
In this study, we investigated the function of NRG1-ErbB4
signaling in amygdala. We demonstrate, by stereology analysis,
that ErbB4+ and PV+ neurons are abundant in medial and caudal
regions of BLA and that 59% of PV+ cells expressed ErbB4. PV-
ErbB4/ mice were deficient in tone-cued fear conditioning.
Expression of ErbB4 in amygdala was sufficient to rescue
tone-cued fear conditioning in PV-ErbB4/ mice. In addition,
we found that neutralizing endogenous NRG1 enabled LTP in
amygdala by reducing GABAergic and impaired tone-cued fear
conditioning. These results suggest that the activity of endo-
genous NRG1 was at saturated level and was critical for high
GABAergic activity in the amygdala. Together, these observa-
tions identified a critical role of NRG1-ErbB4 signaling in control-
ling neuronal activity of the amygdala and fear conditioning.
RESULTS
High GABAergic Activity in Amygdala Gates LTP
Field excitatory postsynaptic potentials (fEPSPs) in the BLAwere
recorded in response to stimulation of the internal capsule fibers
(thalamic input). Occasionally, population spikes may be elicited
(Figure S1A available online); however, we focused on fEPSPs
that were not accompanied with population spikes. The fEPSPs
could be inhibited by 6-cyano-7-nitroquinoxaline-2,3-dione
(CNQX), suggesting that they were mediated by non-NMDA
glutamate receptors (Figure S1A). Tetanic stimulation in the
absence of GABAA receptor antagonist elicited LTP at CA3-
CA1 synapses in the hippocampus but not in amygdala (Figures
S1B and S1C). This observation is in agreement with previous re-
ports (Bissie`re et al., 2003; Rammes et al., 2000; Siguro`sson
et al., 2010; Wang et al., 2004). To investigate underlying cellular
mechanisms, we studied input-output relationships of evoked
excitatory postsynaptic currents (eEPSCs) and inhibitory post-
synaptic currents (eIPSCs) in the BLA and in CA1 region. Pyrami-
dal neurons (Figure S1D) were held at 70 mV, the reversal
potential of GABAA receptor-mediated currents (Figures S2A–
S2C), and recorded for eEPSCs in response to stimuli at various836 Neuron 84, 835–846, November 19, 2014 ª2014 Elsevier Inc.intensities (5 mA to 45 mA) (Figures S1E–S1G). Same neurons
were recorded for eIPSCs after the holding voltage was changed
to 0 mV (Figures S1E–S1G), the reversal potential of glutamate
receptor-mediated currents (Figures S2D–S2F). Both eEPSCs
and eIPSCsweremonosynaptic because of short and consistent
onset latency and rising phase (data not shown). The input-
output curves of eEPSCs in both regions were intensity depen-
dent and similar (Figures S1E and S1F), indicating similar gluta-
matergic input for pyramidal neurons in the two regions. Howev-
er, the eIPSC input-output curve was shifted toward left and
upward in amygdala, compared with hippocampus (Figures
S1E and S1F), which indicated higher GABAergic activity in
amygdala. In agreement, eIPSC/eEPSC ratios were larger in
amygdala than in hippocampus (Figure S1G). These may sug-
gest that the inability to induce LTP in the amygdala is due to
higher GABAergic activity. To test this, amygdala slices were
treated with bicuculline methiodide (BMI), an antagonist of
GABAA receptor, for 30min prior to LTP induction. The treatment
enabled LTP in amygdala (Figures S1H and S1I). These results
indicate that blockade of GABAA receptors enables LTP induc-
tion in BLA.
To further test this idea, we induced LTP in BLA by spike-
timing stimulation in whole-cell configuration, which is related
with associative learning (Feldman, 2012). Under our condition,
EPSPs had short onset latency and consistent rising phase;
and the latency did not change in response to stimulation at
increasing intensity and during LTP, suggesting that they were
monosynaptic (Figures S3A and S3B). Occasional polysynaptic
EPSPs were not included in analysis. The EPSPs were inhabit-
able by CNQX, suggesting that they were mediated by non-
NMDA glutamate receptors (Figure S3A). However, stimulation
of thalamic input paired with postsynaptic firing in amygdala
elicit LTP only in the presence of BMI (Figures S3C and S3D).
The paired-pulse ratio of eEPSPs was not altered before and af-
ter LTP, and LTP was inhibited by BAPTA in recording pipettes
(Figures S3C–S3E), suggesting that LTP is postsynaptic. These
data suggest that synaptic plasticity in amygdala is under tight
control of GABAergic activity.
NRG1 Maintenance of GABAergic Activity in Amygdala
To investigate mechanisms of high GABAergic transmission in
amygdala, we studied the effect of NRG1 on eIPSCs. NRG1 is
known to promote GABAergic transmission in hippocampus
and prefrontal cortex (Chen et al., 2010b; Wen et al., 2010;
Woo et al., 2007). Acute treatment with NRG1 increased eIPSC
amplitudes in the CA1 region (Chen et al., 2010b) (t test, p <
0.05; Figure 1A). Unexpectedly, NRG1 had no effect on BLA
eIPSCs (t test, p > 0.05; Figure 1A) or input/output curve (Fig-
ure S4A). Because NRG1 did not alter eEPSCs either (Fig-
ure S4C), it did not change eIPSC/eEPSC ratios (Figure 1C).
In contrast, however, treatment with ecto-ErbB4, a neutralizing
peptide of NRG1 (Chen et al., 2010b; Wen et al., 2010;
Woo et al., 2007), reduced eIPSCs by 35 ± 5% in amygdala
(t test, p < 0.01; Figure 1B) and caused downward shift
of the input-output curve (Figure S4B). These suggest that
GABAergic activity in BLA is controlled by endogenous NRG1,
maybe at saturated level. In agreement, AG1478, an inhibitor
of ErbB kinases (Woo et al., 2007), reduced eIPSC amplitudes
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Figure 1. NRG1-ErbB4 Signaling Is Neces-
sary for GABAergic Activity in Amygdala
(A) Increased eIPSCs in NRG1-treated hippocam-
pal slices but not in amygdala slices. Slices were
treated with 2 nM NRG1 for 20 min. Left, quanti-
tative analysis; right, representative traces: black,
before treatment; brown, after BMI treatment; red
(amygdala) or green (hippocampus), with NRG1.
n = 9 amygdala neurons, 4mice; t test, p > 0.05; n =
6 hippocampal neurons, 3 mice, t test, p < 0.05.
(B) Decreased eIPSCs in ecto-ErbB4- and
AG1478-treated slices. eIPSCs were recorded as
in (A), in BLA pyramidal neurons before (control,
black) and 20 min after the addition of vehicle
(yellow) or indicated chemicals (5 nMNRG1, green;
2 mg/ml ecto-ErbB4, red; or 5 mM AG1478, blue).
Left, quantitative analysis; right, representative
traces; n = 7 vehicle-treated neurons, 3mice, t test,
p > 0.05; n = 5 NRG1-treated neurons, 2 mice, t
test, p > 0.05; n = 8 ecto-ErbB4-treated neurons, 4
mice, t test, p < 0.05; n = 10 AG1478-treated
neurons, 4 mice, t test, p < 0.05.
(C) No effect by NRG1 on eIPSC/eEPSC ratios in
amygdala. eIPSCs and eEPSCs were recorded at
holding potentials of 0 mV and 70 mV, respec-
tively, before (control) and after treatment with
2 nM NRG1. n = 5 neurons, 3 mice, two-way
ANOVA, F(1, 72) = 0.1551, p > 0.05. Inset, repre-
sentative traces.
(D) ecto-ErbB4 decreased eIPSC/eEPSC ratios in
amygdala. eIPSCs and eEPSCs were recorded as
in (C), except treatment with 2 mg/ml ecto-ErbB4.
n = 9 neurons, 5 mice, two-way ANOVA, F(1, 72) =
22.03, p < 0.001. Inset, representative traces.
(E) High levels of ErbB4 and its activity in BLA. BLA
and hippocampal slices were treated without or
with 5 nM NRG1 and homogenized. ErbB4 and
p-ErbB4 were revealed by western blot analysis.
(F) Quantification of ErbB4 and p-ErbB4 in (E). n = 3
mice per group, *p < 0.05, one-way ANOVA.
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NRG1 Control of GABAergic Activity in Amygdalaby 30 ± 4%, comparedwith controls (n = 10, p < 0.01) (Figure 1B),
suggesting a role of ErbB4 kinases in maintaining GABAergic ac-
tivity. Notice that ecto-ErbB4 had no effect on eEPSCs (Figures
S4B and S4D). Because of reduced eIPSC, the eIPSC/eEPSC
ratios were reduced in ecto-ErbB4-treated slices (Figure 1D).
To determine whether NRG1-ErbB4 activity is elevated in
amygdala, we examined the ErbB4 level and its phosphorylation.
As shown in Figures 1E and 1F, the level of ErbB4 was higher
in BLA than in hippocampus. Basal phospho-ErbB4 was also
higher in BLA than in hippocampus, in agreement with high
GABAergic activity in BLA compared to that in hippocampus at
the basal level (Figure S1). Moreover, stimulation with exoge-
nous NRG1 increased phospho-ErbB4 in hippocampal slices
but not that in BLA slices. The data suggest higher NRG1-
ErbB4 activity in amygdala than in hippocampus.
To determine whether NRG1-controlled GABAergic activity
gates LTP in amygdala, we treated slices with NRG1 or ecto-
ErbB4, which were continuously present during LTP recording.
In control slices, LTP was unable to be induced in NRG1-treated
amygdala (102 ± 2.25%, p > 0.05; Figures 2A and 2B). However,
ecto-ErbB4 enabled LTP induction (118 ± 4.01%, p < 0.05; Fig-ures 2A and 2B). This suggests that high GABAergic activity in
amygdala is maintained by NRG1 and prevents LTP expression.
Ecto-ErbB4, by neutralizing endogenous NRG1, enables LTP by
reducing GABAergic activity. Because inhibition of GABAergic
transmission promotes LTP in amygdala (Figures S1H and
S1I), we next determined if the effect of ecto-ErbB4 was oc-
cluded by GABAergic blockage. Amygdala slices were treated
with ecto-ErbB4 alone or together with BMI. As shown in Figures
2A and 2B, although either ecto-ErbB4 or BMI enabled LTP
expression in amygdala, their combination did not further
enhance LTP. These results provide evidence that neutralization
of endogenous NRG1 promotes LTP by attenuating GABAergic
transmission in amygdala.
ErbB4 is necessary for NRG1 promotion of GABA release
(Woo et al., 2007). To determine if ErbB4 is required for high
GABAergic activity in amygdala, we prepared slices from
ErbB4/;ht+ mice, an ErbB4 null strain that expresses ErbB4
specifically in the heart to prevent embryonic lethality (Tidcombe
et al., 2003; Woo et al., 2007) (Figure 2C), and recorded them for
eIPSCs and eEPSCs. As shown in Figure 2D and Fig-
ure S5, the eIPSC/eEPSC ratios in ErbB4/;ht+ slices wereNeuron 84, 835–846, November 19, 2014 ª2014 Elsevier Inc. 837
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Figure 2. NRG1-ErbB4 Signaling Gates LTP in BLA
(A) ecto-ErbB4 enabled LTP in amygdala, and this effect could not be further enhanced by GABAA receptor inhibition. Slices were treated with 2 nM NRG1,
2 mg/ml ecto-ErbB4, or 20 mMBMI plus ecto-ErbB4 30 min prior to LTP induction. Left, normalized fEPSP amplitudes; dotted line, the baseline; arrow, the time of
induction. Right, representative traces.
(B) Quantitative analysis of data in (A). n = 6 vehicle-treated slices, 3mice; n = 6 NRG1-treated slices, 3mice, one-way ANOVA, p > 0.05; n = 7 ecto-ErbB4-treated
slices, 4 mice, one-way ANOVA, p < 0.05; n = 7 (BMI + ecto-ErbB4)-treated slices, 4 mice, p < 0.05, in comparison with control; one-way ANOVA, p > 0.05, in
comparison to ecto-ErbB4.
(C) No ErbB4 expression in the brain of ErbB4/;ht+ mice. b-actin served as loading control. Shown were representative blots of two mice of each genotype.
(D) Decreased eIPSC/eEPSC ratios in ErbB4/;ht+ amygdala slices. n = 18 neurons, 4 ErbB4+/+mice; n = 12 neurons, 4 ErbB4/;ht+mice, two-way ANOVA,
F(1, 252) = 19.83, p < 0.05.
(E) Enabled LTP in amygdala from ErbB4/;ht+mice could not be further enhanced by BMI. Left, normalized fEPSP amplitudes of different genotypes; dotted
line, the baseline; arrow, time of induction. Right, representative traces.
(F) Quantitative analysis of data in (E). n = 7 slices, 4 ErbB4+/+mice; n = 7 slices, 4 ErbB4/;ht+mice; n = 7 slices, 4 ErbB4/;ht+mice + BMI, t test, *p < 0.05.
Neuron
NRG1 Control of GABAergic Activity in Amygdaladecreased, compared with control, suggesting the dependence
of GABAergic activity on ErbB4. Unlike controls where LTP could
not be induced (Figures S1B and S1C), robust fEPSP LTP was
induced in ErbB4/;ht+ BLA by tetanic stimulation (at 100 Hz
for 1 s) of the thalamic input fibers (Figures 2E and 2F) (control:
103 ± 2.81%, n = 7; ErbB4/;ht+: 121 ± 3.95%, n = 7, p <
0.05), suggesting that ErbB4 negatively regulates LTP in amgy-
dala. BMI enabled LTP in amygdala (Figures S1H and S1I) but
did not further increase ErbB4 mutation-enhanced LTP (Figures
2E and 2F) (ErbB4/;ht+ plus BMI: 124 ± 3.06%, n = 6, p >
0.05, compared to that in ErbB4/;ht+), indicating the depen-
dence on GABAergic activity. Together, these observations
support the notion that GABAergic activity in amygdala for LTP
gating is under tight control of NRG1 and ErbB4.
NRG1 Signaling in Amygdala Is Necessary for
Tone-Cued Fear Conditioning
To determine if NRG1 regulates the function of amygdala, we
examined the effect of NRG1 on tone-cued fear conditioning.838 Neuron 84, 835–846, November 19, 2014 ª2014 Elsevier Inc.Mice were first adapted to test chambers for 3 days before ster-
eotaxical injection of NRG1 or vehicle on day 4. Postmortem
analysis indicated precise delivery of toluidine dye in BLA at
used coordinates (Figure 3A). On day 5, after adaptation to a
set of startle stimulations, mice were subjected to a pretraining
test, tone-cued fear conditioning training at 5 min or 24 hr, test
1, and test 2 (Figure 3B, see Experimental Procedures for de-
tails). As shown in Figures 3C and 3D, the startle response was
similar between vehicle- and NRG1-treated mice in tests 1 and
2 (n = 6 for each groups), suggesting that exogenous NRG1
had no effect on fear conditioning. Injection of ecto-ErbB4 had
no effect on fear-potentiated startle response 5 min after training
(i.e., test 1) (Figure 3C), but it impaired tone-cued fear condition-
ing 24 hr after training (i.e., test 2) (Figure 3D; n = 6 for each
groups), indicating the dependence on endogenous NRG1.
Thus, NRG1 signaling is necessary for 24 hr fear conditioning.
This effect requires ErbB4 because ErbB4/;ht+ mice were
impaired in tone-cued fear conditioning, compared with
ErbB4+/+;ht+ mice in a freezing test (Figure 3E).
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Figure 3. Impairment of Tone-Cued Fear Conditioning by Injection of ecto-ErbB4, but Not NRG1
(A) Microinjection of toluidine blue (1%, 0.2 ml) into amygdala. Shown is a representative section 24 hr after injection. High-magnification micrographs correspond
to black rectangles. Arrow indicates the injection needle track. Left and right scale bars, 500 mm and 50 mm, respectively.
(B) Schematic diagram of the tone-cued fear conditioning paradigm. Mice were subjected to a 5 min adaptation each day from days 1 through 3. On day 4, mice
were injected with vehicle, NRG1, or ecto-ErbB4 into BLA. On day 5, mice received ten pairs of tone cue with foot shock for fear conditioning training. Fear-
potentiated startle response was recorded before training or 5 min after and 24 hr after training.
(C) Fear-potentiated startle test 5 min after training (test 1). n = 6 for each group; two-way ANOVA, F(2, 45) = 0.742, p > 0.05.
(D) Decreased tone-cued startle response in ecto-ErbB4-, but not NRG1-injected, mice 24 hr after training (test 2). n = 6 for each groups; two-way ANOVA, F(2,
45) = 5.264, p < 0.05.
(E) Reduced freezing time in ErbB4/;ht+ mice, two-way ANOVA, F(1, 70) = 123.2, p < 0.05. n = 8 mice for each group.
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NRG1 Control of GABAergic Activity in AmygdalaErbB4 in Amygdala Is Critical for Tone-Cued Fear
Conditioning
To determine whether ErbB4 in amygdala is critical, we injected
adeno-associated virus (AAV) expressing Cre recombinase and
green fluorescence protein (GFP) (AAV-Cre-GFP) into both
sides of the amygdala of floxed-ErbB4+/+ mice, where the
ErbB4 gene is flanked by loxP (Chen et al., 2010b; Wen et al.,
2010). Expression of Cre and GFP was detected in injected
amygdala (Figure 4A). The ErbB4 level was reduced in the
amygdala of AAV-Cre-GFP-injected mice, compared with con-
trol AAV-GFP (Figure 4B). eIPSCs and eEPSCs were recorded
in BLA pyramidal neurons that did not express GFP but were
adjacent to GFP-expressing neurons. eIPSC/eEPSC ratios of
AAV-Cre-GFP-injected amygdala were depressed, compared
with AAV-GFP-injected controls (Figure 4C), indicating
decreased ErbB4 expression, specifically in amygdala altered
inhibition/excitation (I/E) balance. LTP was inducible and
elevated in AAV-Cre-GFP-injected amgydala but not in AAV-
GFP-injected amygdala (Figures 4D and 4E). Remarkably,
ErbB4 reduction in amygdala impaired tone-cued freezing fear
conditioning (p < 0.05, Figure 4F). These observations demon-strate that ErbB4 in amygdala is necessary for tone-cued fear
conditioning.
ErbB4 in PV+ Neurons Is Necessary for Tone-Cued Fear
Conditioning
ErbB4 is detected in PV+ neurons in the prefrontal cortex and hip-
pocampus (Fazzari et al., 2010; Neddens and Buonanno, 2010;
Wen et al., 2010). PV+ cells account for more than half of
GABAergic interneurons in amygdala (Kemppainen and Pitka¨nen,
2000).Whileourworkwas inprogress, a recent study reported that
themajority of PV+ cells in the amygdalawere not ErbB4+ (Shamir
et al., 2012).We visited this issue by crossing ErbB4-2A-CreERT2
mice that express tamoxifen-inducible Cre under control of the
ErbB4 gene (Madisen et al., 2010; Shamir et al., 2012) with Ai14
mice that carry in the Rosa 26 locus a CAG-driven red fluorescent
protein variant (tdTomato) whose transcription was inhibited by a
loxP-flanked stop cassette. The resulting ErbB4-2A-CreERT2;
Ai14mice were injected with tamoxifen to release the stop signal
and thus induce tdTomato expression (Bean et al., 2014). We
found the regional difference of PV+ and ErbB4+ neurons in BLA
by stereological analysis (Figure 5; Figure S6A). The number ofNeuron 84, 835–846, November 19, 2014 ª2014 Elsevier Inc. 839
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Figure 4. Specific Ablation of ErbB4 in Amygdala Decreased eIPSCs/eEPSCs Ratios, Increased LTP in Amygdala, and Impaired Tone-Cued
Fear Conditioning
(A) Expression of GFP and Cre in virus-injected mice. Amygdala sections were examined for GFP fluorescence and Cre staining 4 weeks after stereotaxic
microinjection of AAV-GFP or AAV-Cre-GFP into the amygdala of adult floxed-ErbB4+/+ mice. Scale bar, 50 mm.
(B) Reduced ErbB4 expression in amygdala of floxed-ErbB4+/+ mice injected with AAV-Cre-GFP, compared with AAV-GFP-injected mice. a-tubulin serves as
loading control. Shown were representative blots of two mice of each treatment.
(C) Decreased eIPSC/eEPSC ratios in AAV-Cre-GFP-injected amygdala. Recording was done 3 weeks after injection. n = 13 neurons, 4 mice for both groups;
two-way ANOVA, F(1, 216) = 4.983, p < 0.05.
(D) LTP induction at thalamo-amygdala synapses of AAV-Cre-GFP- but not AAV-GFP-injected mice. Left, normalized EPSP slopes. Dotted line, the baseline;
arrow, the time of induction. Right, representative traces.
(E) Quantitative analysis of data in (D). n = 7 slices, 3 mice for both groups; t test, *p < 0.05.
(F) Impaired fear conditioning in AAV-Cre-GFP-injected, floxed-ErbB4+/+ mice. n = 8 for each group; one-way ANOVA, F(1, 70) = 129.1, p < 0.05.
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NRG1 Control of GABAergic Activity in AmygdalaPV+ and ErbB4+ cells was low in the rostral region of BLA, in
agreement with a previous report (Shamir et al., 2012), but
increased in caudal BLA (Figure 5): a total of 7.01 ± 3.44% of
ErbB4+ neurons were positive for PV in rostral BLA (Figure 5).
However, this number increased to 37.8 ± 0.68% in caudal BLA.
The number of ErbB4+ cells among PV+ neurons were also lower
in rostral BLAbut increased in caudal BLA (27.4 ± 9.1%and78.5±
0.77% for rostral and caudal BLA, respectively; Figure 5). There-
fore, a majority of PV+ cells in caudal BLA express ErbB4.
To test whether ErbB4 in PV+ neurons is necessary for tone-
cued fear conditioning, we studied PV-ErbB4/ mice (Chen
et al., 2010b; Wen et al., 2010), where the ErbB4 level in amyg-
dala was reduced (Figure 6A). ErbB4 was not abolished because
it is also expressed in PV-negative neurons (Figure 5). Ablation of
ErbB4 in PV+ interneurons depressed eIPSC/eEPSC ratios in840 Neuron 84, 835–846, November 19, 2014 ª2014 Elsevier Inc.amygdala (Figure 6B), suggesting a critical role of ErbB4 in PV in-
terneurons. In control PV-ErbB4+/+ BLA, LTP could not be eli-
cited at thalamo-amygdala synapses. However, LTP was readily
detectable in PV-ErbB4/ BLA. Moreover, treatment with BMI,
which enabled LTP expression in BLA (Figure 1H), did not further
increase LTP in PV-ErbB4/ BLA (one-way ANOVA, p > 0.05,
compared to PV-ErbB4/; Figures 6C and 6D). CGP52432,
an antagonist of GABAB receptor, had no effect on LTP in control
or PV-ErbB4/ slices (Figures 6C and 6D), suggesting that
GABAB receptor was not involved (Pan et al., 2008). These re-
sults demonstrated that ErbB4 in PV+ interneurons is critical
for high threshold for LTP induction.
When white noise (85 dB, 30 s) was used as a conditioned
stimulus (CS), white noise-cued fear conditioning in the freezing
test was similar between PV-ErbB4/ and control littermates
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Figure 5. ErbB4 Expression and Colocalization with PV in BLA
(A and B) Schematic diagrams of coronal sections of BLA. BLA was divided into rostral, medial, and caudal regions, each 0.3 mm in thickness.
(C) Costaining of PV with tdTomato-expressing neurons. Sections of rostral, medial, and caudal amygdala were prepared from adult ErbB4-2A-CreERT2;Ai14
mice and stained for PV (green). Unfilled triangles, tdTomato (red)-positive neurons without PV; filled triangles, PV-positive neurons without dtTomato; arrows,
PV- and tdTomato-positive neurons. Top and bottom scale bars, 200 mm and 50 mm, respectively.
(D) Stereological analysis of ErbB4+ and PV+ neurons in BLA rostral, medial, and caudal regions. Three mice were studied. t test, *p < 0.05.
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NRG1 Control of GABAergic Activity in Amygdala(Figure 6F), in agreement with a recent report (Shamir et al.,
2012). Because white noise may be less sensitive than a high-
frequency tone (Calandreau et al., 2006), we analyzed freezing
in PV-ErbB4/ with a tone (5000 Hz, 30 s, 70 dB) as the CS.
Remarkably, fear memory in the freezing test was impaired in
PV-ErbB4/ mice, compared with controls (Figure 6E), sug-
gesting that ErbB4 in PV+ neurons may be necessary for tone-
cued fear conditioning. Next, we examined PV-ErbB4/ mice
using startle fear conditioning test (as diagrammed in Figure 3B).
The startle response was similar between control and PV-
ErbB4/ mice 5 min after training, when white noise or tone
was used as the cue (data not shown). There was no difference
in startle response between control and PV-ErbB4/ mice
24 hr after training with white noise as the cue (p > 0.05) (Fig-
ure S6D). In contrast, the startle response 24 hr after tone-
cued training was reduced in PV-ErbB4/ mice compared
with control mice (Figure S6C). Together with the freezing test,
these results corroborate that ErbB4 in PV+ neurons is crucial
for tone-cued fear conditioning.
Rescue of Deficits in PV-ErbB4–/– Mice by ErbB4
Expression in Amygdala
Next, we determined whether BLA ErbB4 is sufficient to
control the I/E balance and for tone-cued fear conditioning in
PV-ErbB4/ mice. Lentivirus (LV)-ErbB4 (Flag-tagged) was
injected into the amygdala, which could infect 63%PV+ interneu-rons in BLA (Figure S7). ErbB4 levels were increased in the amyg-
dala of injected PV-ErbB4/ mice, compared with controls
(injected with LV-GFP) (Figure 7A). The increase was due to the
expression of viral Flag-ErbB4 because it was recognized by
anti-Flag antibody (Figure 7B). ErbB4 expression increased I/E
ratios in response to stimulation higher than 25 mA (Figure 7C).
LTP was diminished in LV-ErbB4-injected amygdalas of
PV-ErbB4/ mice (Figures 7D and 7E). As shown in Figure 7F,
LV-ErbB4 infection significantly improved toned fear memory,
compared with LV-GFP injection. These results indicated that
specific expression of ErbB4 in the amygdala is sufficient to
reverse synaptic dysfunction and tone-cued fear conditioning in
PV-ErbB4/mice.
DISCUSSION
Our study identifies a critical role of NRG1-ErbB4 signaling in
amygdala function by modulating GABAergic output of PV+
interneurons. First, NRG1-ErbB4 signaling is at saturated levels
in the amygdala, which maintains high GABAergic activity.
Neutralizing endogenous NRG1 or pharmacological or genetic
ablation of ErbB4 reduces GABAergic transmission (Figure 1)
and enables LTP at thalamo-amygdala synapses (Figure 2).
Second, tone-cued fear conditioning is impaired in mice that
were injected with the neutralizing peptide ecto-ErbB4 into the
amygdala (Figure 3) or in ErbB4 mutant mice (Figure 3). Third,Neuron 84, 835–846, November 19, 2014 ª2014 Elsevier Inc. 841
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Figure 6. Decreased eIPSCs/eEPSCs Ratios
and Increased LTP in Amygdala and Im-
paired Tone-Cued Fear Conditioning in PV-
ErbB4–/– Mice
(A) Reduced ErbB4 expression in PV-ErbB4/
amygdala. Amygdala lysates of 3-month-old mice
were probed for ErbB4 and a-tubulin as loading
control. Shown were representative blots of two
mice of each genotype.
(B) Reduced eIPSC/eEPSC ratios in PV-ErbB4/
amygdala. n = 10 neurons, 4 PV-ErbB4+/+ mice;
n = 11 neurons, 4 PV-ErbB4/ mice; two-way
ANOVA, F(1, 171) = 52.36, p < 0.05.
(C) LTP induction at thalamo-amygdala synapses
in amygdala slices of PV-ErbB4/ mice, but not
PV-ErbB4+/+ mice, and the effect could not be
further increased by BMI or decreased by
CGP52432 (10 mM). Left, normalized EPSP slopes
of indicated genotypes with treatment; dotted line,
the baseline; arrow, time of induction. Right,
representative traces.
(D) Quantitative analysis of data in (C). n = 7
slices, 3 PV-ErbB4+/+ mice; n = 8 slices, 3 PV-
ErbB4/ mice; n = 7 slices, 3 PV-ErbB4/
plus BMI mice, n = 8 slices, 3 PV-ErbB4+/+ plus
CGP52432 mice; n = 7 slices, 3 PV-ErbB4/
plus CGP52432 mice; one-way ANOVA, *p <
0.05.
(E) Reduced tone-cued fear conditioning in PV-
ErbB4/ mice. n = 8 for each group; two-way
ANOVA, F(1, 70) = 157.8, p < 0.05.
(F) No difference in white-noise-cued fear conditioning between PV-ErbB4/ and PV-ErbB4+/+ mice. A behavioral test was performed as in Figure 3E,
except tone was replaced by white noise. n = 8 for each groups two-way ANOVA, F(1, 70) = 1.127, p > 0.05.
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NRG1 Control of GABAergic Activity in Amygdalaa majority of PV+ neurons in BLA express ErbB4 (Figure 5). Spe-
cific ablation of ErbB4 in amygdala reduces the I/E ratio and
impairs cued fear conditioning (Figure 4). It is important to note
that expression of ErbB4 in amygdala is sufficient to diminish
synaptic dysfunction and rescue tone-cued fear conditioning in
PV-ErbB4/ mice (Figures 6 and 7).
The amygdala is critical for acquiring and storing emotional
memories, memory consolidation, and modulating emotionally
related memory in other brain areas (Davis and Whalen, 2001;
LeDoux, 2000; McGaugh, 2004; Sah et al., 2003). Amygdala
projection neurons are heavily innervated by GABAergic inter-
neurons. GABA activity is critical for synaptic plasticity and
fear learning (Bissie`re et al., 2003; Lang and Pare´, 1998; Li
et al., 1996; Mahanty and Sah, 1998; Pare´ and Gaudreau,
1996; Sah et al., 2003; Sugita et al., 1993; Woodruff and Sah,
2007), especially in memory acquisition and consolidation (Ehr-
lich et al., 2009; Johansen et al., 2011). However, in contrast
to the cortex and hippocampus, regulatory mechanisms of
GABAergic activity in the amygdala are not well understood.
Our morphological studies including stereology show that
ErbB4+ and PV+ neurons are not evenly distributed in BLA, be-
ing relatively sparse in the rostral region (Shamir et al., 2012) but
abundant in the caudal region (Figure 5). In amygdala BLA,
although 26% of ErbB4+ cells are positive for PV, ErbB4 is ex-
pressed in 59% of PV+ cells (Figure S6). In the hippocampus
and cortex, PV+ interneurons such as basket cells and chande-
lier cells target soma and axon initial segments of pyramidal
neurons (Kepecs and Fishell, 2014). One chandelier cell could842 Neuron 84, 835–846, November 19, 2014 ª2014 Elsevier Inc.innervate more than 1,200 pyramidal cells (Li et al., 1992). Being
strategically positioned, PV+ cells control spiking and synchro-
nized activity. Therefore, a parsimonious explanation of our
results is that, by controlling 59% of PV+ interneurons in amyg-
dala BLA, NRG1-ErbB4 is likely to exert a profound effect on
firing of pyramidal neurons.
Differing strength of NRG1-ErbB4 signaling between
amygdala and hippocampus may explain different levels of
GABAergic activity in the two regions. High GABAergic activity
in amygdala is thought to maintain lower firing rate of pyramidal
neurons and thus enables animals to respond only to appropriate
sensory signals. In BLA, feed-forward GABAergic interneurons
synapse heavily onto BLA projection neurons (Li et al., 1996; Szi-
nyei et al., 2000). Consequently, thalamo-amygdala LTP is diffi-
cult to elicit in naive slices (Bissie`re et al., 2003; Shaban et al.,
2006; Shin et al., 2006; Tully et al., 2007). Attenuation of
GABAA transmission facilitates the induction of LTP (Bissie`re
et al., 2003; Shaban et al., 2006; Shin et al., 2006; Tully
et al., 2007). We show that NRG1-ErbB4 signaling regulates
GABAergic outputs in amygdala (Figure 1). In behavioral anal-
ysis, PV-ErbB4/ mice were impaired in both freezing and
startle fear conditioning tests (Figures 6 and S6). Moreover,
expression of ErbB4 in amygdala is sufficient to rescue tone-
cued fear conditioning in PV-ErbB4/mice (Figure 7). In partic-
ular, tone-cued fear conditioning is impaired by neutralizing
peptide ecto-ErbB4 (Figure 3) or by ErbB4 mutation (Figure 3).
These results reveal a critical function of NRG1-ErbB4 signaling
in regulating the function of amygdala.
Figure 7. Rescue of Fear Conditioning Defi-
cits of PV-ErbB4–/– Mice by ErbB4 Expres-
sion in Amygdala
(A) Expression of Flag-tagged ErbB4 in the amyg-
dala of LV-ErbB4-injected mice. Mice were in-
jected with-LV-ErbB4 (0.2 ml) virus into amygdala,
and after 1 week, amygdala was isolated for
western blotting with anti-Flag antibody. a-tubulin
serves as loading control. Shown were represen-
tative blots of two mice of each injection.
(B) Restoration of ErbB4 expression in PV-
ErbB4/ amygdala by viral injection. Mice of
indicated genotypes were injected with control
virus (LV-GFP) or LV-ErbB4, and after one week,
amygdala was isolated for western blotting with
anti-ErbB4 antibody. a-tubulin served as loading
control. Shown were representative blots of two
mice of each genotype.
(C) Increased eIPSC/eEPSC ratios in LV-ErbB4-
injected amygdala, compared with LV-GFP-in-
jected controls. Recording was conducted 1 week
after injection, as in (A). n = 11 neurons, 3 LV-GFP-
injected PV-ErbB4/ mice; n = 9 neurons, 3 LV-
ErbB4-injected PV-ErbB4/ mice; two-way
ANOVA, F(1, 162) = 5.524, p < 0.05.
(D) Suppression of LTP at thalamo-amygdala
synapses in whole-cell configuration by ErbB4
expression.PV-ErbB4/micewere injected as in
(A). Left, normalized fEPSP slopes of indicated
mice; dotted line, the baseline; arrow, time of in-
duction. Right, representative traces.
(E) Quantitative analysis of data in (D). n = 8 slices,
4 LV-GFP-injected PV-ErbB4/ mice; n = 8 sli-
ces, 4 LV-ErbB4-injected PV-ErbB4/ mice for
both groups; t test, *p < 0.05.
(F) Restored fear conditioning in PV-ErbB4/
mice that expressed ErbB4 in amgydala. n = 8 for
each group; two-way ANOVA, F(1, 70) = 50.62, p <
0.05.
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NRG1 Control of GABAergic Activity in AmygdalaIn amygdala, reduced inhibitory activity is typically associated
with enhanced LTP, which is thought to facilitate fear condi-
tioning (Muller et al., 1997; Wilensky et al., 1999). However,
inhibition of NRG1-ErbB4 signaling decreases GABAergic activ-
ity, disrupts the I/E balance, and enhances LTP but impairs fear
conditioning (Figures 4 and 6). A number of studies also suggest
association of hippocampal LTP enhancement with impaired
learning and memory in mice that lack PSD-95 (Migaud et al.,
1998), Fmr2 (Gu et al., 2002), PDE4D (Rutten et al., 2008), or
IRSp53 (Kim et al., 2009). The exact cellular mechanism of
this association remains unclear. Altered I/E balance is believed
to be a pathophysiological mechanism of many psychological
diseases, such as autism and schizophrenia (Kehrer et al.,
2008; Yizhar et al., 2011). A parsimonious hypothesis is that
learning and memory require bidirectional synaptic plasticity
or proper range for neuronal excitation for information process-
ing (Malenka, 1994). If synapses become unmodifiable, as in
relevant mutant mice, synaptic plasticity such as LTP become
sustained, which may prevent new information acquisition
and/or storage by or within the network. When ErbB4 is mutated
in PV+ interneurons, LTP was enhanced in the amygdala.
Because of the loss of GABAergic activity, more synapsesbecome potentiated, and synapses in the amygdala lose
‘‘bidirectional plasticity.’’ Consequently, unmodifiable LTP may
prevent information storage and recall capacity. This notion is
supported by the observations that ecto-ErbB4 injected mice
and PV-ErbB4/ mice had no problem in learning fear condi-
tioning behavior but were abnormal 24 hr after the training.
These results demonstrate that abnormal enhancement of LTP
and the I/E ratio may be detrimental to fear memory and sug-
gest that dynamic regulation of synaptic plasticity in the amyg-
dala is necessary. To our knowledge, this may be a first report
of association of enhanced amygdala LTP with impaired fear
memory.
Schizophrenic patients are impaired in cognitive function as
well as in emotion processing, including fear memory (Lewis
and Sweet, 2009), and exhibit reduced neural activity in the
amygdala and its projection in response to fear perception
(Aleman and Kahn, 2005; Rasetti et al., 2009). Both ErbB4
and NRG1 are susceptibility genes of schizophrenia (Mei and
Nave, 2014; Mei and Xiong, 2008). Erbb4 deletion from fast-
spiking interneurons causes schizophrenia-like phenotypes
(Del Pino et al., 2013). Our findings provide insight into not
only physiological functions of NRG1-ErbB4 in amygdala butNeuron 84, 835–846, November 19, 2014 ª2014 Elsevier Inc. 843
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NRG1 Control of GABAergic Activity in Amygdalaalso pathophysiological mechanisms of disrupted NRG1-ErbB4
signaling in schizophrenia-related deficits.
EXPERIMENTAL PROCEDURES
Animals
Mice had ad libitum access to water and food and were housed under a 12 hr
light/dark cycle. Experimental procedures were approved by the Institutional
Animal Care and Use Committee of Georgia Regents University.
Immunohistochemistry, Immunoprecipitation, and Western Blotting
Analysis
Immunohistochemistry, immuoprecipitation, and western blotting were per-
formed as described previously (Huang et al., 2000; Yin et al., 2013a). Detailed
information was provided in Supplemental Experimental Procedures.
Electrophysiological Analysis
Brains were quickly removed from anesthetized mice and chilled in ice-cold
modified artificial cerebrospinal fluid (ACSF). Coronal hippocampal and amyg-
dala slices were cut using a VT-1000S vibratome and transferred to a chamber
containing regular ACSF for recording. Thalamic afferent fibers were stimu-
lated with a concentric bipolar electrode (FHC), and fEPSPs in the BLA were
recorded in current-clamp using the Multi-Clamp 700B (Molecular Devices)
amplifier with ACSF-filled glass pipettes (1–5 MU). Stimuli consisted of mono-
phasic 100-ms pulses of constant currents at 0.033 Hz. LTP was induced by a
train of 100 pulses at the same intensity in 1 s. Values were normalized to the
baseline 30 min prior to LTP induction. fEPSPs and LTP in hippocampus were
recorded as previously described (Chen et al., 2010b; Ma et al., 2003). To
obtain the I/E ratio, monosynaptic eIPSCs and eEPSCs were recorded in
pyramidal neurons by patch-clamp in whole-cell configuration. Stimulating
electrode was positioned on the thalamic fiber path in the BLA, 100 mm
from the recording electrode. For thalamic whole-cell LTP recording, stimula-
tion electrodes were positioned on thalamic fibers outside the BLA. To induce
LTP, a train of 80 stimuli at 2 Hz was delivered to internal capsule fibers. Each
stimulus was paired with action potentials evoked by depolarizing currents
(1 nA, 4 ms) with controlled delay (4-10 ms) from the onset of each eEPSP.
Detailed information was provided in Supplemental Experimental Procedures.
Virus Production and Injection
Flag-tagged ErbB4 was subcloned into pFUGM LV vector (kindly provided
by Dr. Hongjun Song). pFUGM-ErbB4, pCMVDR8.92, and pVSVG were co-
transfected into HEK293FT cells, and LV-ErbB4 was harvested with 109 trans-
ducing units per milliliter. Expression was controlled by a cytomegalovirus
promoter in both LV-ErbB4 and LV-GFP (Rattiner et al., 2004). Adult mice
(8–10 weeks old) were anesthetized with ketamine/xylazine (Sigma; 100/
20 mg/kg, respectively, intraperitoneally) and head-fixed in a stereotaxic de-
vice (David Kopf Instruments). Injection coordinates are as follows: anteropos-
terior, 1.8; dorsoventral, 4.8; mediolateral, ±3.2 relative to bregma. Virus
and dye were slowly pressure injected (0.2 ml per side, 0.02 ml/min) through
a glass pipette (Cetin et al., 2006) (tip size, 20 mm). AAV-GFP and AAV-
Cre-GFP (Vector BioLabs, catalog # 7007 and #7020, respectively) were deliv-
ered with titer 1011 copies (genome copies) per milliliter.
Tone-Cued Fear Conditioning
For the startle fear conditioning test, on days 1–3, mice were allowed for envi-
ronmental adaptation in a test box of the Startle Reflex System (Med Associ-
ates) for 5 min per day, without acoustic stimulus. They were injected on day 4
with NRG1 (10 mM, 0.2 ml), ecto-ErbB4 (1 mg/ml, 0.2 ml), or vehicle. On day 5,
after 5 min environmental adaptation, mice were subjected to an initial set of
white-noise startle stimulations at three different intensities (100, 105, and
110 dB, 20 ms 3 3) that were delivered in a pseudorandom manner. Subse-
quently, they were subjected to a pretraining test that consisted of randomly
delivered startle stimulations (total, 18) with or without tone cue (CS) (70 dB,
5000 Hz, 30 s), and startle response was measured by a load cell stabilimeter
that detects cage movement within the first 100 ms after onset of the startle
stimulus. Startle response without CS was designated as response 1 (R1),844 Neuron 84, 835–846, November 19, 2014 ª2014 Elsevier Inc.and startle response with CS was designated as R2 response 2 (R2). Mice
were then subjected to fear conditioning training, consisting of a CS paired
with a foot shock immediately after (0.5 s, 1 mA). Fear conditioning behavior
was tested 5 min or 24 hr after training (test 1 and test 2, respectively). Startle
response in the pretraining test, test 1, and test 2 was calculated as% = (R2
R1)/R1. Fear-potentiated startle response was calculated as test 1 or 2 minus
the pretraining test.
The freezing fear conditioning test was conducted in sound-attenuating
chambers (73 7.53 15 in) on metal grid floors that could generate foot shock
(Med Associates). After adaptation for 3 days (5min/day), micewere subjected
to two fear conditioning pairings of 30 s CS (tone at 70 dB, 5000 Hz, or white
noise at 70 dB) and foot shock (0.5 s, 1 mA) at the end of the CS. The intertrial
interval was 1 min. Mouse freezing was monitored by an infrared camera and
analyzed using MED-PC software. One day after pairing, the freezing test was
conducted by placing mice in a different test chamber (8 3 9 3 7.5 in), where
the metal grid floor was covered and a vanilla extract olfactory cue was pre-
sent, for 3 min without CS and 2 min with CS. Chambers were cleaned with
70% ethanol before each use.
Data Analysis
Data were analyzed by one-way or two-way ANOVA and Student’s t test, with
post hoc Newman-Keuls tests for multiple comparisons. Data were presented
as means ± SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.neuron.2014.09.029.
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